Secchi, O., Franchi, A. and Lunello, A. (2023) “Comments to ‘Cost per responder for vedolizumab and ustekinumab in Crohn’s disease patients after failure of TNF-α inhibitors in Italy’”, AboutOpen, 10(1), pp. 82–86. doi: 10.33393/ao.2023.2600.